The US launched a trade probe into German pharmaceutical payments, coinciding with Trump pursuing a hardline trade strategy.
6 reports, 6 independent
Updated Jun 20
Gone quiet
Reached 4 outlets in its first 24 hours
- Reports
- 6
- Developments
- 7
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The US launched a trade probe into German pharmaceutical payments, coinciding with Trump pursuing a hardline trade strategy.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Roberta Metsola advised Germany to seek a deal with the Trump administration amid an ongoing drug pricing trade dispute.Sub-event
US government launched a trade probe into Germany regarding drug pricing.1 source
US trade probe into Germany over pharma pricing, involving Merz and Greer.1 source
Trump pursues hardline trade strategy amid US probe into German pharma payments.1 source
US investigating German drug pricing policies, leading to potential Trump tariffs on Germany.1 source
US launches trade investigation into German drug pricing, directed by Trump.1 source
US Trade Representative Greer oversees investigation into German drug pricing practices.1 source
Keep exploring
The entities involved
-
Jamieson Greer
United States Trade Representative since 2025
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
Washington
township in Bergen County, New Jersey, United States
-
Friedrich Merz
German politician, Chancellor of the Federal Republic of Germany